Watch how Baysient’s T3 application supports precision dosing for Vedolizumab IV therapy. In this video, we walk through a case involving an 80 kg patient, showing how T3 leverages patient-specific data to recommend optimal dosing intervals and achieve therapeutic goals.

Key highlights include:

✔ Generating individualized dosing recommendations based on patient-specific metrics.

✔ Understanding how dosing intervals impact trough concentrations and overall treatment outcomes.

✔ Utilizing probability charts to evaluate antibody risk and remission likelihood.

See how T3 empowers providers to move beyond standard dosing regimens, providing personalized care that enhances patient outcomes and treatment durability.